Tissue and Organ ProcurementTissue DonorsBrain DeathOrgan TransplantationPresumed ConsentLiver TransplantationKidney TransplantationTissue and Organ HarvestingWaiting ListsDirected Tissue DonationCadaverTransplantation, HomologousDeathDonor SelectionOocyte DonationTissue BanksLiving DonorsOrgan PreservationHeart TransplantationGraft SurvivalTransplantationUnited States Health Resources and Services AdministrationPrinciple-Based EthicsBone Marrow TransplantationFacility Regulation and ControlHealth Care RationingHematopoietic Stem Cell TransplantationLung TransplantationUnited StatesGraft RejectionTransplantation, AutologousInformed ConsentLiver FailureTransplantsEnd Stage Liver DiseasePancreas TransplantationValue-Based PurchasingRetrospective StudiesTreatment OutcomeStem Cell TransplantationTime FactorsEthics, MedicalTransplantation ConditioningIslets of Langerhans TransplantationFamilyBlood DonorsPatient SelectionAltruismRegistriesTransplantation ImmunologyLiver DiseasesCell TransplantationTransplantation ChimeraFacial TransplantationOrgan Preservation SolutionsImmunosuppressive AgentsDrugs, EssentialGraft vs Host DiseaseHistocompatibility TestingGift GivingTransplantation, IsogeneicTransplantation, HeterotopicMedicarePosthumous ConceptionHeart-Lung TransplantationCord Blood Stem Cell TransplantationRisk FactorsTissue PreservationPostoperative ComplicationsTransplantation ToleranceRisk AssessmentCold IschemiaImmunosuppressionCorneal TransplantationProportional Hazards ModelsPurchasing, HospitalPeripheral Blood Stem Cell TransplantationFetal Tissue TransplantationResource AllocationFollow-Up StudiesDelayed Graft FunctionSkin TransplantationThird-Party ConsentNephrectomyDissectionSurvival RateTissue TransplantationRaffinoseHistocompatibilityTransplantation, HeterologousRecurrenceKidney Failure, ChronicMesenchymal Stem Cell TransplantationLiverEmbryo DispositionSperm BanksTacrolimusHepatectomyHematologic NeoplasmsCyclosporine